Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582751 · ClinicalTrials.gov registry record
Volumetric Analysis in the Assessment of Therapy Response by CT
A clinical trial of Multiple Diseases, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 26
- Enrollment target
- 1
- Study location
NCT00582751: Completed study of Multiple Diseases, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00582751 is a study of Multiple Diseases that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582751, a study of Multiple Diseases, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare the volumetric response achieved using semi-automated computer techniques with the uni-dimensional (RECIST) and bi-dimensional (WHO) criteria as part of clinical trials running at MSKCC, testing new agents for different types of solid tumors.
Conditions Studied
Study Locations (1)
New York
- Memorial Sloan-Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-11 |
What the finished NCT00582751 record still lists
NCT00582751 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 1 condition, with Multiple Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT00582751 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00582751 about?
NCT00582751 is a clinical study titled "Volumetric Analysis in the Assessment of Therapy Response by CT". To compare the volumetric response achieved using semi-automated computer techniques with the uni-dimensional (RECIST) and bi-dimensional (WHO) criteria as part of clinical trials running at MSKCC, testing new agents for different types of solid tumors.
What is the current status of trial NCT00582751?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2007-11. Estimated completion is 2010-11.
What conditions does trial NCT00582751 study?
This clinical trial studies the following conditions: Multiple Diseases.
Who is sponsoring clinical trial NCT00582751?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00582751 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia